Medtronic Diabetes Company Profile

07:50 EST 13th December 2018 | BioPortfolio

At Medtronic Diabetes, our 20 plus year history vividly reflects our dedication and ongoing vision to develop an "artificial pancreas". In 1983, we pioneered the idea of continuous insulin delivery, introducing our first insulin pump in an effort to find a "better way" to deliver insulin for people with diabetes. Since that time, Medtronic Diabetes has remained the market leader, earning a reputation for excellence in insulin pump therapy and continuous glucose monitoring.


18000 Devonshire Street
United States of America

News Articles [1594 Associated News Articles listed on BioPortfolio]

Medtronic Acquires Nutrino Health to Integrate Diabetes Capabilities with Nutritional Data

Medtronic acquires Nutrino Health to augment diabetes capabilities with Nutrino’s nutritional database and data science.  Medtronic, a provider of medical technology announced it will acquire Tel A...

Medtronic, IBM Watson debut AI-powered diabetes management app

The artificial intelligence-powered Sugar.IQ smart diabetes assistant has been released by Medtronic and IBM Watson Health to -More- 

Medtronic acquires Israeli nutrition data startup Nutrino Health

Medtronic said the company will be rolled into its Diabetes Group to improve its diabetes management capabilities by adding Nutrino’s comprehensive

Medtronic announces commercially availability of AI-powered diabetes management app

Medtronic, along with its technology partner IBM Watson Health, has announced commercially availability of artificial intelligence (AI) powered Sugar.IQ diabetes management app.

Medtronic and UnitedHealthcare’s Value-based Relationship Results in Lower Costs, Fewer Hospital Readmissions

Today, Medtronic and UnitedHealthcare announced positive first-year results from their value-based relationship focused on improving health outcomes for people with diabetes. Results demonstrated cost...

Medtronic Launches the MiniMed 670G System Performance Guarantee for Payers and Employers

Medtronic (NYSE:MDT), the global leader in medical technology, announced the launch of the MiniMed(TM) 670G Performance Guarantee Program – an outcomes-based offering for payers and employers d...

Medtronic buys Israeli nutrition data co Nutrino

The Tel Aviv-based nutrition-relateddata services, analytics,and technologies company will be integrated into Medtronic's Diabetes Group.

Medtronic gets US FDA nod for use of MiniMed 670G system patients with type 1 diabetes seven years of age and older

Medtronic plc, the global leader in medical technology, announced that the US Food and Drug Administration (FDA) has approved the use of the MiniMed 670G system in patients with type 1 diabetes seven ...

Drugs and Medications [43 Associated Drugs and Medications listed on BioPortfolio]

Prialt® (ziconotide intrathecal infusion) [Elan Pharmaceuticals, Inc.]

PRIALT® (ziconotide intrathecal infusion)

Scot-tussin diabetes cough formula with dm [SCOT-TUSSIN Pharmacal Co., Inc.]

Scot-Tussin Diabetes Cough Formula with DM

Aspirin [Time-Cap Labs, Inc]


Novolin [Novo Nordisk]

Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)

Metformin hydrochloride [Solco Healthcare US LLC]

Rx only Metformin hydrochloride tablets(Metformin hydrochloride tablets, USP)

PubMed Articles [2006 Associated PubMed Articles listed on BioPortfolio]

Performance of Medtronic Hybrid Closed-Loop Iterations, Results from a Randomized Trial in Adolescents with Type 1 Diabetes.

This study investigates the performance of an iteration of the Medtronic hybrid closed-loop (HCL) algorithm, which utilizes sensor glucose values non-adjunctively for bolus advice, recognizes sustaine...

Battery Longevity Comparison of Two Commonly Available Dual Channel Implantable Pulse Generators Used for Subthalamic Nucleus Stimulation in Parkinson's Disease.

Deep brain stimulation for Parkinson's disease (PD) utilises an implantable pulse generator (IPG) whose finite lifespan in non-rechargeable systems necessitates their periodic replacement. We wish to ...

Gender differences in diabetes self-care in adults with type 1 diabetes: Findings from the T1D Exchange clinic registry.

To evaluate gender differences in diabetes self-care components including glycemic, blood pressure and lipid control, utilization of diabetes technologies and acute diabetes complications in adults wi...

Depression and diabetes distress in adults with type 2 diabetes: results from the Australian National Diabetes Audit (ANDA) 2016.

This study explores the prevalence of, and factors associated with, likely depression and diabetes distress in adults with type 2 diabetes in a large, national sample. Australian National Diabetes Aud...

Optimizing a Hybrid Closed Loop System in Type 1 Diabetes: A Case Report.

We present the optimization of a hybrid closed-loop (HCL) insulin pump system in a type 1 diabetes (T1D) patient in the first 3 months of using the Minimed 670G. An 11-year-old female with 7 years o...

Clinical Trials [5311 Associated Clinical Trials listed on BioPortfolio]

A Study of LY900014 in a Medtronic Pump

The purpose of this study is to compare the study drug LY900014 to insulin lispro (Humalog) when both are delivered by the Medtronic MiniMed 670G System in adults with type 1 diabetes (T1D...

Glycemic Control and the Brain in Children With Type 1 Diabetes

The purpose of this study is to determine if improving diabetes control by better controlling blood sugars, will help improve or normalize brain function as compared to routine diabetes ca...

Hypoglycaemia and Cardiac Arrhythmias in Type 2 Diabetes

Twenty-one patients with insulin-treated type 2 diabetes with diabetic complications will be recruited to Part 1 of the study, a three-hour combined hyper- and hypoglycaemic clamp, along w...

Utility of the Audible Alert in Current Generation Medtronic Implantable Cardioverter-defibrillators

The purpose of this study is to determine whether the alert tones emitted by the latest generation of Medtronic implantable cardioverter-defibrillators (ICDs) are audible to patients. ...

Spinal Cord Stimulation (SCS) Therapy Study

The purpose of this study is to evaluate the effect of different spinal cord stimulation settings in the treatment of leg pain. Subjects will receive a randomized order of four different p...

Companies [528 Associated Companies listed on BioPortfolio]

Medtronic Diabetes

At Medtronic Diabetes, our 20 plus year history vividly reflects our dedication and ongoing vision to develop an "artificial pancreas". In 1983, we pioneered the idea of continuous insulin delivery, i...

Medtronic, Inc.

Medtronic, Inc. (, headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health, and extending life for mil...

Medtronic plc

Medtronic plc (, headquartered in Dublin, Ireland, is the global leader in medical technology – alleviating pain, restoring health and extending life for ...

Medtronic Foundation & Project HOPE

Medtronic, Inc. (, headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health, and extending life for million...

Functional Neuromodulation, Ltd

Founded in Toronto, Ontario in 2010, Functional Neuromodulation is dedicated to advancing the application of deep brain stimulation (DBS) therapies to help improve the lives of pe...

More Information about "Medtronic Diabetes" on BioPortfolio

We have published hundreds of Medtronic Diabetes news stories on BioPortfolio along with dozens of Medtronic Diabetes Clinical Trials and PubMed Articles about Medtronic Diabetes for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Medtronic Diabetes Companies in our database. You can also find out about relevant Medtronic Diabetes Drugs and Medications on this site too.

Quick Search


Relevant Topic

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...

Corporate Database Quicklinks

Searches Linking to this Company Record